Ana Tomás
Impact in
-
- Antibiotic Use and Resistance
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Antibiotic Use and Resistance 13
-
- Pharmaceutical Practices and Patient Outcomes 8
- Co-authors
- Milica Paut KusturicaAna SaboOlga HorvatZ. TomićNebojša StilinovićAleksandar RaškovićSuzanne ErbOle Mors
- Journals
- Frontiers in Public Health (3 papers)Clinical Therapeutics (3 papers)Antibiotics (3 papers)Saudi Pharmaceutical Journal (2 papers)International Journal of Environmental Research and Public Health (2 papers)
- Partner nations
- SerbiaSwitzerlandBosnia and Herzegovina
In The Last Decade
Ana Tomás
50 papers receiving 714 citations
Peers
Comparison fields: 5 of 124
- Applied Microbiology and Biotechnology 159
- Geriatrics and Gerontology 93
- Biological Psychiatry 38
- Behavioral Neuroscience 47
- Molecular Medicine 58
Countries citing papers authored by Ana Tomás
This map shows the geographic impact of Ana Tomás's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Tomás with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Tomás more than expected).
Fields of papers citing papers by Ana Tomás
This network shows the impact of papers produced by Ana Tomás. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Tomás. The network helps show where Ana Tomás may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ana Tomás, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 14 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 7 | |
| 11 | 2022 | 16 | |
| 12 | 2022 | 0 | |
| 13 | 2022 | 8 | |
| 14 | 2021 | 2 | |
| 15 | 2021 | 22 | |
| 16 | 2020 | 28 | |
| 17 | 2020 | 9 | |
| 18 | 2020 | 16 | |
| 19 | 2020 | 11 | |
| 20 | 2019 | 10 |
About Ana Tomás
Ana Tomás is a scholar working on Applied Microbiology and Biotechnology, Geriatrics and Gerontology, Molecular Medicine, Family Practice and Pharmacology, having authored 59 papers that have together received 732 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (13 papers), Pharmaceutical Practices and Patient Outcomes (8 papers), Antibiotic Resistance in Bacteria (8 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Blood Pressure and Hypertension Studies (5 papers), Pneumonia and Respiratory Infections (4 papers), Pharmaceutical and Antibiotic Environmental Impacts (4 papers) and Pharmaceutical Economics and Policy (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (159 citations), Geriatrics and Gerontology (93 citations), Biological Psychiatry (38 citations), Behavioral Neuroscience (47 citations) and Molecular Medicine (58 citations). Ana Tomás has collaborated with scholars based in Serbia, Switzerland and Bosnia and Herzegovina. Frequent co-authors include Milica Paut Kusturica, Ana Sabo, Olga Horvat, Z. Tomić, Nebojša Stilinović, Aleksandar Rašković, Suzanne Erb, Ole Mors, Katherine J. Aitchison and Anne Farmer. Their work appears in journals such as Frontiers in Public Health, Clinical Therapeutics, Antibiotics, Saudi Pharmaceutical Journal and International Journal of Environmental Research and Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.